Lexaria Bioscience Corp. - Director's Dealing 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-09-25	Common Shares	P	10000	$0.1899	Acquired	5334586	Direct
2015-09-25	Common Shares	P	1000	$0.19	Acquired	5335586	Direct
2015-09-25	Common Shares	P	20200	$0.18	Acquired	5355786	Direct
2015-09-25	Common Shares	P	10000	$0.178	Acquired	5365786	Direct
2015-09-25	Common Shares	P	2500	$0.178	Acquired	5368286	Direct
2015-09-25	Common Shares	P	5000	$0.175	Acquired	5373286	Direct
2015-09-25	Common Shares	P	5000	$0.17	Acquired	5378286	Direct
2015-09-25	Common Shares	P	7000	$0.1775	Acquired	5385286	Direct
2015-09-25	Common Shares	P	4704	$0.1694	Acquired	5389990	Direct
2015-09-25	Common Shares	P	15000	$0.17	Acquired	5404990	Direct
2015-09-25	Common Shares	P	5000	$0.162	Acquired	5409990	Direct
2015-09-25	Common Shares	P	15000	$0.164	Acquired	5424990	Direct
2015-09-25	Common Shares	P	10000	$0.1598	Acquired	5434990	Direct
2015-09-25	Common Shares	P	5000	$0.1599	Acquired	5439990	Direct
2015-09-25	Common Shares	P	20000	$0.16	Acquired	5459990	Direct
2015-09-25	Common Shares	P	8000	$0.1685	Acquired	5467990	Direct
2015-09-25	Common Shares	P	25000	$0.1699	Acquired	5492990	Direct
2015-09-25	Common Shares	P	5000	$0.165	Acquired	5497990	Direct
2015-09-28	Common Shares	P	10000	$0.18	Acquired	5507990	Direct
2015-09-28	Common Shares	P	5000	$0.179	Acquired	5512990	Direct

Security	Shares	Ownership
Common Shares	4488958	Indirect
Common Shares	5324586	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.11	2019-12-23	Common Shares (500000)	500000	Direct
Stock Options	$0.35	2016-07-11	Common Shares (200000)	700000	Direct
Stock Options	$0.1	2018-06-18	Common Shares (225000)	925000	Direct
Warrants	$0.25	2017-05-15	Common Shares (170000)	170000	Indirect